Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A2BO
|
||||
Former ID |
DIB003121
|
||||
Drug Name |
S-110
|
||||
Synonyms |
SGI-110; DNA demethylating agent (myelodysplastic syndrome), Supergen
|
||||
Indication | Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] | Phase 3 | [525074] | ||
Company |
SuperGen Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
OC[C@@H]1[C@@H](OP(=O)(OC[C@H]2O[C@@H](n3c4nc([nH]c(=O)<br />c4nc3)N)C[C@@H]2O)[O-])C[C@@H](O1)n1c(=O)nc(nc1)N.[Na+]
|
||||
Target and Pathway | |||||
Target(s) | DNMT1 | Target Info | Inhibitor | [530893] | |
Pathway Interaction Database | Regulation of retinoblastoma protein | ||||
PathWhiz Pathway | Methionine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.